(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 3.4% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.58%.
Innospec's revenue in 2025 is $1,789,200,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2025 to be $45,070,421,658, with the lowest IOSP revenue forecast at $42,914,772,024, and the highest IOSP revenue forecast at $46,804,852,398. On average, 5 Wall Street analysts forecast IOSP's revenue for 2026 to be $47,349,959,202, with the lowest IOSP revenue forecast at $44,822,645,838, and the highest IOSP revenue forecast at $49,183,500,270.
In 2027, IOSP is forecast to generate $49,778,162,238 in revenue, with the lowest revenue forecast at $47,572,957,440 and the highest revenue forecast at $51,512,592,978.